Event JSON
{
"id": "40eb0dc5925c249471018353267b972d8fab96c9b93df6613fdd9d485113dc10",
"pubkey": "261776f4b97d13687d2213896785134f9a251d249618a68586a9b85a117b1377",
"created_at": 1702080081,
"kind": 1,
"tags": [
[
"t",
"Tech"
],
[
"t",
"arstechnica"
],
[
"t",
"it"
],
[
"t",
"technology"
],
[
"t",
"sicklecelldisease"
],
[
"t",
"sicklecellanemia"
],
[
"t",
"hemoglobin"
],
[
"t",
"science"
],
[
"t",
"health"
],
[
"proxy",
"https://mastodon.roitsystems.ca/users/TechNews/statuses/111547520190293327",
"activitypub"
]
],
"content": "Ars Technica: FDA approves first CRISPR therapy—here’s how it works against sickle cell https://arstechnica.com/?p=1989840 #Tech #arstechnica #IT #Technology #sicklecelldisease #sicklecellanemia #hemoglobin #Science #Health",
"sig": "f688d4b1dda464e39abee17d7ab3b7e560792961461b5e20f155b51c45876d92413cb48b4c1186bd06d613048c4aac2932d52f023f1f3c032ee0db94dad542c3"
}
